Research shows nearly half of people with type 2 diabetes stop taking GLP-1 drugs within a year due to factors like cost and side effects
Insulin tells the bodys cells to take in blood glucose, decreasing glucose levels in the blood
The free program gives patients a science-backed support system designed to address multiple challenges associated with GLP-1s, such as the need to prioritize protein, managing common side effects, and preserving muscle mass while losing weight
The mechanisms overlap, but the timeline is dramatically accelerated by rapid fat loss
Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrn B, Sjholm A
They often occur when you first start tirzepatide, or when you increase your dosage, and usually improve with time